‡a
Author's High expression of HIF1a is a predictor of clinical outcome in patients with pancreatic ductal adenocarcinomas and correlated to PDGFA, VEGF, and bFGF.
‡a
Author's Proteomic differences between hepatocellular carcinoma and nontumorous liver tissue investigated by a combined gel-based and label-free quantitative proteomics study.
‡a
highexpressionofhif1aisapredictorofclinicaloutcomeinpatientswithpancreaticductaladenocarcinomasandcorrelatedtopdgfavegfandbfgf
‡A
High expression of HIF1a is a predictor of clinical outcome in patients with pancreatic ductal adenocarcinomas and correlated to PDGFA, VEGF, and bFGF.
‡9
1
‡a
preoperativesurvivinmrnadetectioninperipheralbloodisanindependentpredictorofoutcomeinesophagealcarcinoma
‡A
Preoperative survivin mRNA detection in peripheral blood is an independent predictor of outcome in esophageal carcinoma
‡9
1
‡a
proteomicdifferencesbetweenhepatocellularcarcinomaandnontumorouslivertissueinvestigatedbyacombinedgelbasedandlabelfreequantitativeproteomicsstudy
‡A
Proteomic differences between hepatocellular carcinoma and nontumorous liver tissue investigated by a combined gel-based and label-free quantitative proteomics study.
‡9
1
